ClinicaliQ Trial Snapshot
- Episealer® Knee System IDE Clinical Study — Active Not Recruiting • Non-phase study • NCT04000659.
- Episealer Knee System treats painful knee cartilage damage in a randomised controlled trial comparing its effectiveness against standard treatment.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The study is a randomized, prospective, multicenter, controlled clinical trial of the Episealer Knee System. The Episealer Knee System is intended for subjects with up to two focal femoral knee chondral or osteochondral lesion that is causing pain and/or disability and requires surgical treatment. Conditions: Degenerative Lesion of Articular Cartilage of Knee Interventions: Episealer Knee System, Microfracture Lead Sponsor: Episurf Medical Inc. Planned Enrollment: 13 participants